期刊文献+

儿童横纹肌肉瘤“上海儿童医学中心Rs-99方案”临床报告 被引量:8

Results of protocol SCMC Rs-99 for childhood rhabdomyosarcoma
原文传递
导出
摘要 目的 改善儿童横纹肌肉瘤、生殖细胞性肿瘤、Ewing’s肉瘤等恶性实体瘤预后。 方法 对 1998年10月至 2 0 0 1年 10月明确诊断的横纹肌肉瘤及其它软组织肉瘤、生殖细胞性肿瘤、Ewing’s肉瘤患儿共 17例 ,采用上海儿童医学中心Rs 99方案 ,即外科手术、内科化疗、选择性放疗、病理科与影像学科协作诊断、综合治疗。按方案中条件根据危险因素进行分组 ,并按分组给予分级治疗。结果  17例恶性实体瘤患儿中 4例自行终止治疗并失访 ,12例获完全缓解 ,1例部分缓解 6个月后进展死亡。随访至 2 0 0 2年 9月 ,12例获缓解者中 1例 2 2个月时复发后死亡 ;1例 2 4个月时复发带病生存至今 35个月。另 10例持续缓解 15~ 4 6个月 ,平均为 2 8个月 ,其中 9例已停药平均 17个月。结论 Rs 99方案诊断及治疗对横纹肌肉瘤、生殖细胞性肿瘤、Ewing’s肉瘤有效。 Objective To improve the results of childhood rhabdomyosarcoma,germ cell tumor,Ewing's sarcoma and other solid tumor.Methods Diagnosis and treatment were performed by the multi disciplinary term which included oncologist,surgeon,pathologist,radiologist and diagnostic radiologist.Protocol Rs 99,designed by our term,was used.Patients were grouped by risk factors and treated with different intensity depending on grouping.Results Seventeen patients were enrolled,four of them stopped their treatment by their parents and lost follow up.Twelve reached complete response and one achieved partial response for 6 months and then progressed to death.Two in 12 relapsed and one of them died,one live with disease for 34 months till now.The other ten patients were still in CR for an average 28 months.Nine of them already stopped the treatment depending on the protocol.Conclusion Multi disciplinary term work is an effective model for childhood cancer.The protocol Rs 99 achieves good results in this study.
出处 《中国实用儿科杂志》 CSCD 北大核心 2003年第4期208-211,共4页 Chinese Journal of Practical Pediatrics
关键词 儿童 横纹肌肉瘤 诊断 治疗 危险因素 临床报告 上海儿童医学中心 Rs-99方案 Rhabdomyosarcoma\ Germ cell tumor\ Ewing's sarcoma\ Treatment
  • 相关文献

同被引文献59

  • 1王建文.小儿横纹肌肉瘤[J].实用儿科临床杂志,2005,20(1):6-7. 被引量:15
  • 2李巍松,施诚仁.儿童软组织肉瘤的化疗[J].临床外科杂志,2005,13(5):321-323. 被引量:4
  • 3唐锁勤,黄东生,王建文,冯晨,杨光.大剂量化疗造血干细胞移植治疗IV期神经母细胞瘤的长期疗效研究[J].中国当代儿科杂志,2006,8(2):93-96. 被引量:27
  • 4Horowitz ME, Malawer MM, Woo SY, et al. Ewing's sarcoma family of tumors: Ewing's sarcoma of bone and soft tissue and the peripheral primitive neuruectodermal tumors//Philip A. Principles and Practice of Pediatric Oncolugy. 3rd ed. Philadelphia: Lippincutt-Raven Publishers ,2000 : 831-863.
  • 5Marec-Berard P, Philp T. Ewing sarcoma: the pediatrician's point of view. Pediatr Blood Cancer,2004, 42 : 477-480.
  • 6Kolb EA, Kushner BH, Gorlick R, et al. Long-term event-free survival after intensive ehenaotherapy for Ewing's family of tumors in children and young adults. J Clin Oncol, 2003, 21 : 3423- 3430.
  • 7Oberlin O, Deley MC, Bui BN, et al. Prognostic factors in localized Ewing's tumors and peripheral neuroectodermal tumours: the third study of the French Sociaty of Paediatric Oncology (EW88 study). Br J Cancer,2001, 85 : 1646-1654.
  • 8Bernstein ML, Devidas M, Eafreniere D, et al. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase Ⅱ Study 9457 - a report from the Children's Oncology Group. J Clin Oncol, 2006, 24: 152-159.
  • 9Miser JS, Krailo MD, Tarbell NJ, et al. Treatment of metastatic Ewing's sarcoma or primitive neuoectodermal tumor of bone: evaluation of combination ifosfamide and etoposide-a Children's Cancer Group and Pediatric Oncology Group Study. J Clin Oncol, 2004, 22: 2873-2876.
  • 10Hendershot E. Treatment approaches for metatatie Ewing's sarcoma : a review of the literature. J Pedia Oncol Nur,2005,22 : 339-352.

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部